The Integra Nutritionals® nutrigenomic approach is much less reliant on traditional disease-based markers and much more focused on nutrient-based and metabolic markers. For this reason, the tests selected here provide valuable information to assist the clinician in monitoring the status of relevant key markers.
The tests are convenient for both the clinician and the patient who may self-collect the sample if the consultation is not face-to-face. With their rapid turnaround time from sampling to results, the blood spot tests are an ideal
way for a clinician to measure a patient’s response to treatment.
What are the benefits?
We have chosen tests which give very good representation of your patient’s diet and lifestyle over a period of
time and are ideal to test before, during and following treatment.
• Enhanced patient monitoring
• Ability to incorporate test reviews into appointment schedule
• Better patient compliance
• Enable individualised treatment
An imbalance of fatty acids in the lipid bilayer of all our body’s cells may be reflective of an imbalanced diet. Consuming high-quality omega-3 rich foods increases the amount of EPA and DHA stored in our cell membranes, a factor that has profound effects upon our overall health. The test measures several parameters inlcuding the percentage of EPA + DHA in the RBC wall. An ideal result is 8% or more, with the Japanese typically 12%. The Omega-3 Complete profile is not only useful for cardiovascular disease monitoring but for chronic disease in general.
The Omega 3 Index is a Scientifically Validated measurement to assess the potential of a person’s dietary fat intake to either prevent or promote disease. The test measures 24 individual fatty acid levels in the red blood cells to calculate Omega-3 Index and several other related parameters.
This test is typically repeated in 3-4 months – or even at 2 months in severe cases where closer dosage monitoring is required.